In this issue:
Predictive factors
MicroRNA expression in colon cancer
Early disease
Longer TME trial follow-up data
Advanced disease
HAI regimens in unresectable CRC
Preoperative bevacizumab in hepatic resection
Bevacizumab and 5FU/OX for CLM
OPTIMOX1 outcomes in the elderly
Cetuximab in relapsed colorectal cancer
Cetuximab and bevacizumab and irinotecan
PTEN expression and cetuximab response
Adjuvant chemotherapy
Fluorouracil and folinic acid in colorectal cancer
Please login below to download this issue (PDF)